JAKARTA - The World Health Organization (WHO) has asked India to clarify the export of cough drug supplements that have caused death.
Reuters reported that Wednesday, October 8, WHO will review the need for a Global Medical Products Warning (Global Medical Products Alert) regarding Coldrif silent after receiving official confirmation from Indian authorities.
Deaths from cough mildes from India emerged in the South Asian country. Similar cases also occur in other countries.
At least 17 children under the age of five died in India in the past month after taking cough drugs containing dietilen glycol toxic compounds nearly 500 times the allowed limit.
Cases of children's deaths from consuming cough warranty also occurred in Cameroon, Gambia, and Uzbekistan.
SEE ALSO:
-
| BERITA
Ukraina Rajin Serang Infrastruktur Energi-BBM Rusia, Begini Efek Jangka Panjangnya?
08 Oktober 2025, 14:22
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
